Adamas pharmaceuticals inc (ADMS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Revenues:
Total revenues

14,481

-

-

-

11,665

-

-

-

-

-

1

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total net revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

138

222

175

524

768

398

226

30,301

215

25,154

176

40,110

161

241

30,583

Costs and operating expenses:
Cost of product sales

572

442

929

685

413

435

100

73

25

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

2,465

5,180

6,042

8,598

10,214

10,597

11,709

9,806

7,188

6,445

6,459

7,176

7,088

7,047

7,437

9,224

7,522

9,697

9,960

8,705

7,533

8,517

5,412

5,173

2,758

2,373

1,387

1,572

2,078

Selling, general and administrative, net

24,552

30,285

31,180

25,216

27,688

27,582

27,491

27,699

26,363

22,989

16,064

13,115

9,144

-

7,344

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and operating expenses

27,589

35,907

38,151

34,499

38,315

38,614

39,300

37,578

33,576

-

22,523

20,291

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,058

6,641

-

5,803

5,846

4,919

4,748

4,353

3,262

3,109

2,613

1,571

1,363

1,120

Total costs and operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

16,232

-

14,781

17,282

14,163

16,587

15,763

14,551

12,452

13,265

9,765

8,435

5,867

4,986

2,958

2,935

3,198

Loss from operations

-13,108

-19,559

-24,218

-21,808

-26,650

-25,299

-28,687

-30,013

-31,023

-28,883

-22,522

-20,289

-16,232

-15,293

-14,643

-17,060

-13,988

-16,063

-14,995

-14,153

-12,226

17,036

-9,550

16,719

-5,691

35,124

-2,797

-2,694

27,385

Interest and other income, net

-84

-124

-512

-734

-723

-184

-921

-1,132

-878

-86

-839

-222

-204

-218

-249

-184

-160

-98

-85

-102

-78

116

1

112

688

-

-

-

-

Interest expense

3,624

3,640

3,876

3,797

3,731

3,768

5,386

5,112

4,826

2,239

1,677

729

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-426

-567

-421

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-23,360

-20,796

-

-

-14,394

-16,876

-

-15,965

-14,910

-14,051

-12,148

16,920

-9,551

16,607

-6,379

31,632

-3,223

-3,261

26,964

Benefit for income taxes

-

-

-

-

-

-

-

-

-

-

0

-51

-

-

0

0

-

-5,275

-51

0

54

7,189

6

178

1

688

216

92

195

Net loss

-16,648

-23,075

-27,582

-24,871

-29,658

-28,883

-33,152

-33,993

-34,971

-29,357

-23,360

-20,745

-16,028

-14,960

-14,394

-16,876

-13,828

-10,690

-14,859

-14,051

-12,202

9,731

-9,557

16,429

-6,380

30,944

-3,439

-3,353

26,769

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,557

-

-

22,218

-3,439

-3,353

17,642

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,557

-

-

23,767

-3,439

-3,353

18,378

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

0.79

-0.57

1.05

-0.67

2.33

-0.36

-0.35

1.86

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

0.89

-0.57

0.88

-0.67

2.00

-0.36

-0.35

1.70

Net loss per share, basic and diluted (in dollars per share)

-0.59

-0.83

-0.99

-0.90

-1.08

-1.04

-1.22

-1.26

-1.35

-1.28

-1.04

-0.93

-0.72

-0.68

-0.66

-0.78

-0.65

-

-0.81

-0.78

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,643

17,432

16,787

15,604

9,525

9,512

9,510

9,506

9,496

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,643

23,526

16,787

18,590

9,525

17,410

9,510

9,506

10,798

Weighted average shares used in computing net loss per share, basic and diluted (in shares)

28,030

27,898

27,778

27,579

27,453

27,377

27,266

27,040

25,861

23,065

22,569

22,392

22,206

22,000

21,941

21,650

21,253

-

18,395

17

-

-

-

-

-

-

-

-

-

Product sales
Total revenues

-

-

13,933

12,691

-

13,315

10,613

7,565

2,553

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-